Live from the NIH registry
Studies recruiting near Deltona right now
Top 25 of 954 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Orange City, Florida (6.0 mi)
· Sponsor: American Society of Clinical Oncology
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Advanced Urology Institute - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: Pacific Edge Limited
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Florida Neurology - Lake Mary — Lake Mary, Florida (11.9 mi)
· Sponsor: AbbVie
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
AdventHealth — Altamonte Springs, Florida (19.2 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Orlando, Florida (27.2 mi)
· Sponsor: Dren Bio
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Orlando — Maitland, Florida (21.2 mi)
· Sponsor: RAI Services Company
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - North — Orange City, Florida (6.0 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (22.4 mi)
· Sponsor: AbbVie
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Mid Florida Hematology and Oncology Center ( Site 0152) — Orange City, Florida (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Orlando, Florida (27.2 mi)
· Sponsor: Sameek Roychowdhury
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Orlando, Florida (27.2 mi)
· Sponsor: AstraZeneca
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Orange City, Florida (6.0 mi)
· Sponsor: Daiichi Sankyo
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Eli Lilly and Company
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU — DeLand, Florida (10.1 mi)
· Sponsor: Annovis Bio Inc.
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: Giselle Sholler
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Halifax Health Cancer Center for Hope - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: NRG Oncology
Improving Mechanics and Confidence in the Hip Hinge
Hip Hinge, Hip and Knee Movement
N/A
Interventional 30 participants sought
University of Central Florida — Orlando, Florida (27.2 mi)
· Sponsor: University of Central Florida
OLE Therapy With BE Patients in Home Care Study
Bronchiectasis, Pulmonary Exacerbation
N/A
Interventional 85 participants sought
Central Florida Pulmonary Group, P.A. — Orlando, Florida (27.2 mi)
· Sponsor: Delve Health
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Omega Research Debary, LLC — DeBary, Florida (5.9 mi)
· Sponsor: Philip Morris Products S.A.
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Daytona Beach, Florida (24.1 mi)
· Sponsor: Ambros Therapeutics, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
K2 Medical Research - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
Charter Research, LLC — Orlando, Florida (27.2 mi)
· Sponsor: AC Immune SA
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Sarah Cannon Research Institute @ Florida Cancer — Orlando, Florida (27.2 mi)
· Sponsor: Genentech, Inc.
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Orange City, Florida (6.0 mi)
· Sponsor: AstraZeneca